The Miami Entrepreneur

Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage

Read Time:7 Second

That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post U.S. job growth totaled 275,000 in February but unemployment rate rose to 3.9%
Next post Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move